Table 4.
General health scores.
| Treatment group (isolate) | General appearance | Breathing | Sneezing or coughing | Nasal discharge | Ocular discharge | Total clinical score |
|---|---|---|---|---|---|---|
| T1 (LU298) | 0 | 0 | 4 | 4 | 0 | 8 |
| T2 (UK4182) | 0 | 0 | 3 | 12 | 0 | 15 |
| T3 (NP631) | 0 | 17 | 10 | 5 | 1 | 33a |
| T4 (NP787) | 0 | 0 | 2 | 11 | 0 | 13 |
| T5 (NP742) | 0 | 0 | 17 | 10 | 0 | 27a |
| T6 (control) | 0 | 0 | 0 | 1 | 5 | 6b |
a
Scores heavily weighted by one dog within the group, in both instances the dogs were euthanized on study day 14 and displayed the clinical signs of respiratory disease recorded for throughout the14 day study period. Scores were highest in these dogs on study days 10–13.
b
Scores awarded to one dog in this treatment group which had some serous ocular discharge prior to challenge and throughout the study.